OBJECTIVE: To elucidate the clinical features, surgical treatment, and long-term outcome in elderly patients with moyamoya disease (MMD). METHODS: We retrospectively reviewed 87 elderly patients with MMD at Beijing Tiantan Hospital. Clinical features, radiologic findings, and outcomes were analyzed. RESULTS: The mean age at diagnosis was 54.0 +/- 3.7 years. Familial occurrence was 2.3%. Underlying vascular risk factors was 74.7%. Infarction was the most common symptom in elderly MMD (40.2%). Most patients presented with Suzuki stage 4 or 5 MMD (51.2%). Posterior cerebral artery involvement was observed in 22 (25.3%) patients. The incidence of postoperative infarction or hemorrhages was 6.9%. Diabetes was identified as a predictor of adverse postoperative events. During the average follow-up of 35.5 +/- 22.2 months, rebleeding in patients with hemorrhagic MMD was higher than in those with ischemic MMD (P < 0.05). What's more, the rate of perfusion improvement in surgically treated patients was higher than in conservatively treated patients 3 months after discharge (P < 0.05). CONCLUSIONS: Infarction was the most common symptom in elderly MMD. More vascular risk factors, a higher grade of Suzuki stage, fewer familial cases, and posterior cerebral artery involvement were observed in elderly patients with MMD. Diabetes was a risk factor of postoperative events for elderly patients. Hemorrhagic MMD had a higher rate of rebleeding than the ischemic type. Although surgical revascularization procedures can improve cerebral perfusion, further study is needed to determine whether surgical revascularization is effective in elderly patients or with certain techniques.
基金:
National Science and Technology Major Project of China [2006BAI01A13, 2015BAI12B04]; Program of Beijing Municipal Science and Technology Commission [Z13110200680000]; Program of the National Natural Science Foundation of ChinaNational Natural Science Foundation of China [81371292]
第一作者机构:[1]Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China;[2]China Natl Clin Res Ctr Neurol Dis, Dept Neurosurg, Beijing, Peoples R China;[3]Beijing Inst Brain Disorders, Ctr Stroke, Dept Neurosurg, Beijing, Peoples R China;[4]Beijing Key Lab Translat Med Cerebrovasc Dis, Dept Neurosurg, Beijing, Peoples R China
通讯作者:
通讯机构:[1]Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China;[2]China Natl Clin Res Ctr Neurol Dis, Dept Neurosurg, Beijing, Peoples R China;[3]Beijing Inst Brain Disorders, Ctr Stroke, Dept Neurosurg, Beijing, Peoples R China;[4]Beijing Key Lab Translat Med Cerebrovasc Dis, Dept Neurosurg, Beijing, Peoples R China
推荐引用方式(GB/T 7714):
Ge Peicong,Zhang Qian,Ye Xun,et al.Clinical Features, Surgical Treatment, and Long-Term Outcome in Elderly Patients with Moyamoya Disease[J].WORLD NEUROSURGERY.2017,100:459-466.doi:10.1016/j.wneu.2017.01.055.
APA:
Ge, Peicong,Zhang, Qian,Ye, Xun,Liu, Xingju,Deng, Xiaofeng...&Zhao, Jizong.(2017).Clinical Features, Surgical Treatment, and Long-Term Outcome in Elderly Patients with Moyamoya Disease.WORLD NEUROSURGERY,100,
MLA:
Ge, Peicong,et al."Clinical Features, Surgical Treatment, and Long-Term Outcome in Elderly Patients with Moyamoya Disease".WORLD NEUROSURGERY 100.(2017):459-466